It’s not an easy environment for health-care investors, with the sector front and center of political debates, but a bigger concern might be stemming from a key regulator: the U.S. Food and Drug Administration.
The center, believed to be the first and largest of its kind, will use psychedelics to study the mind and identify therapies for diseases such as addiction, PTSD, and Alzheimer's
Biomedical engineers at Duke University have developed a new platform to create biologic drugs using specially engineered bacteria that burst and release useful proteins when they sense that their capsule is becoming too crowded.
People who have found themselves below the relative poverty threshold four or more times in their adult life age significantly earlier than others. This is shown in new research from the Department of Health and Medical Sciences at the University of Copenhagen.